Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Paxnor Pharma AS
AS
Active
Org 917968306
Sandviksveien 126, 1365
Blommenholm
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2016 · 9 years old
2 employees
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Paxnor Pharma AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
2M
2M
1M
1M
0M
2021: 2M
2M
2021
2022: 2M (0% vs 2021)
2M
0%
2022
2023: 2M (0% vs 2022)
2M
0%
2023
2024: 2M (0% vs 2023)
2M
0%
2024
2025: 2M (0% vs 2024)
2M
0%
2025
EBITDA
NOK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
1 567
2 012
2 330
2 111
2 141
Staff expenses
−1 292
−1 233
−1 463
−1 602
−1 404
EBITDA
−177
287
336
−56
419
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−177
287
336
−56
419
Net financials
−0
−1
−0
−0
−0
Profit before tax
−177
286
336
−56
419
Tax
−0
63
62
−0
87
Net profit
−177
223
275
−56
331
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
816
1 017
1 468
526
724
Equity
602
779
557
282
338
Long-term debt
0
0
0
0
0
Short-term debt
214
238
911
244
385
Total debt
214
238
911
244
385
Financial ratios
5-year trend
EBITDA margin
−11,3 %
This company
15,8 %
Market median
This company
Market median
172% below market
2021
2025
Equity ratio
73,8 %
This company
38,2 %
Market median
This company
Market median
93% above market
2021
2025
Return on equity
−29,4 %
This company
18,4 %
Market median
This company
Market median
260% below market
2021
2025
Net profit margin
−11,3 %
This company
8,1 %
Market median
This company
Market median
240% below market
2021
2025
Asset turnover
1,92×
This company
1,12×
Market median
This company
Market median
71% above market
2021
2025
Debt / equity
0,35×
This company
0,62×
Market median
This company
Market median
44% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on Paxnor Pharma AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
